EFFICACY OF BRIVARACETAM IN PEDIATRIC EPILEPSY: AN UP-TO-DATE
Among the newest antiepileptic drugs, brivaracetam (BRV), previously known as “ucb34714”, is one of the most interesting molecules available, increasingly getting the attention of researchers. The clinical efficacy of BRV as adjunctive therapy has been extensively assessed in six randomized, control...
Guardado en:
Autor principal: | Antonio Nicotera |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Associazione Italiana Giovani Medici
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8a459c6dc1de4afab53dabd6fdeebd23 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A review of the pharmacology and clinical efficacy of brivaracetam
por: Klein P, et al.
Publicado: (2018) -
Brivaracetam in the treatment of epilepsy: a review of clinical trial data
por: Feyissa AM
Publicado: (2019) -
Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
por: L. Abraira, et al.
Publicado: (2021) -
Effects of 12-month Antiepileptic Drug Use on Thyroid Functions in Children: A Retrospective Observational Study
por: Fatma Hancı, et al.
Publicado: (2021) -
Plasma Homocysteine Level in Children under Treatment with Antiepileptic Drugs and its Relation to Intelligence Quotient
por: Mohammed Abo Al-maaty, et al.
Publicado: (2020)